KALV logo

KalVista Pharmaceuticals (KALV) Revenue

Annual revenue:

N/A
April 30, 2024

Summary

  • KALV annual revenue is not available.

Performance

KALV Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVincome statement metrics

Quarterly revenue:

N/A
January 31, 2025

Summary

  • KALV quarterly revenue is not available.

Performance

KALV Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVincome statement metrics

TTM revenue:

N/A
January 31, 2025

Summary

  • KALV TTM revenue is not available.

Performance

KALV TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherKALVincome statement metrics

KALV Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

KALV Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

KALV Revenue History

DateAnnualQuarterlyTTM
Apr 2020
$12.69M(-21.3%)
$3.82M(+142.5%)
$12.69M(+7.6%)
Jan 2020
-
$1.58M(-59.8%)
$11.79M(-16.4%)
Oct 2019
-
$3.92M(+16.4%)
$14.11M(-10.6%)
Jul 2019
-
$3.37M(+15.1%)
$15.78M(-2.2%)
Apr 2019
$16.13M(+92.1%)
$2.93M(-24.8%)
$16.13M(-10.6%)
Jan 2019
-
$3.89M(-30.4%)
$18.04M(+9.5%)
Oct 2018
-
$5.59M(+50.4%)
$16.48M(+37.2%)
Jul 2018
-
$3.72M(-23.2%)
$12.02M(+43.1%)
Apr 2018
$8.39M(+458.1%)
$4.84M(+107.6%)
$8.39M(+128.8%)
Jan 2018
-
$2.33M(+106.8%)
$3.67M(+131.4%)
Oct 2017
-
$1.13M(+1074.0%)
$1.58M(+240.9%)
Jul 2017
-
$96.00K(-15.8%)
$465.00K(+23.7%)
Apr 2017
$1.50M
$114.00K(-54.0%)
$376.00K(+39.8%)
Jan 2017
-
$248.00K(+3442.9%)
$269.00K(+827.6%)
DateAnnualQuarterlyTTM
Sep 2016
-
$7000.00(0.0%)
$29.00K(0.0%)
Jun 2016
-
$7000.00(0.0%)
$29.00K(0.0%)
Apr 2016
$2.13M(+7255.2%)
-
-
Mar 2016
-
$7000.00(-12.5%)
$29.00K(0.0%)
Dec 2015
$29.00K(-98.4%)
$8000.00(+14.3%)
$29.00K(0.0%)
Sep 2015
-
$7000.00(0.0%)
$29.00K(-9.4%)
Jun 2015
-
$7000.00(0.0%)
$32.00K(+6.7%)
Apr 2015
$1.80M(+6120.7%)
-
-
Mar 2015
-
$7000.00(-12.5%)
$30.00K(+3.4%)
Dec 2014
$29.00K(-93.0%)
$8000.00(-20.0%)
$29.00K(-93.1%)
Sep 2014
-
$10.00K(+100.0%)
$419.00K(+2.4%)
Jun 2014
-
$5000.00(-16.7%)
$409.00K(+1.2%)
Mar 2014
-
$6000.00(-98.5%)
$404.00K(+1.5%)
Dec 2013
$415.00K(-73.0%)
$398.00K
$398.00K
Dec 2012
$1.54M
-
-

FAQ

  • What is the all time high annual revenue for KalVista Pharmaceuticals?
  • What is the all time high quarterly revenue for KalVista Pharmaceuticals?
  • What is the all time high TTM revenue for KalVista Pharmaceuticals?

What is the all time high annual revenue for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high annual revenue is $16.13M

What is the all time high quarterly revenue for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high quarterly revenue is $5.59M

What is the all time high TTM revenue for KalVista Pharmaceuticals?

KalVista Pharmaceuticals all-time high TTM revenue is $18.04M
On this page